We are live on
!
Find out more
MC
Mayo Clinic Portfolio holdings
AUM
$2.9M
1-Year Est. Return
14.49%
This Fund
S&P 500
This Quarter
Est. Return
-7.66%
1 Year Est. Return
+14.49%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$88.2M
AUM Growth
–
Cap. Flow
+$88.9M
Cap. Flow
% of AUM
100.86%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
8
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Black Stone Minerals
BSM
|
+$72.6M |
| 2 |
UBX
Unity Biotechnology
UBX
|
+$11.1M |
| 3 |
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
|
+$2.71M |
| 4 |
STEX
Streamex Corp
STEX
|
+$1.37M |
| 5 |
Seres Therapeutics
MCRB
|
+$667K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 82.19% |
| 2 | Healthcare | 16.45% |
| 3 | Financials | 1.36% |
Similar funds
SWS
PWA
CU
QC
SOA
HVM
JC
MIG
Mayo Clinic's Q4 2019 Portfolio in Review
Q4 2019 is the first quarter with a 13F filing on record for Mayo Clinic, which disclosed 8 positions worth $88.2M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Black Stone Minerals: 5,697,748 shares worth $72.5M.
By sector, the portfolio is most concentrated in Energy at 82% of assets, followed by Healthcare and Financials.
- Mayo Clinic's largest Q4 2019 buy was Black Stone Minerals: 5,697,748 shares worth $72.5M.
- Mayo Clinic's ten largest holdings make up 100% of its $88.2M portfolio in Q4 2019.
- Mayo Clinic disclosed 8 positions in Q4 2019, its first 13F filing on record.
Based on Mayo Clinic's 13F filing for Q4 2019, filed 12 Feb 2020.